Cargando…
Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial
BACKGROUND: Fibrinogen is the first coagulation protein to reach critical levels during traumatic haemorrhage. This laboratory study compares paired plasma samples pre- and post-fibrinogen replacement from the Fibrinogen Early In Severe Trauma studY (FEISTY; NCT02745041). FEISTY is the first randomi...
Autores principales: | Morrow, Gael B., Feller, Timea, McQuilten, Zoe, Wake, Elizabeth, Ariëns, Robert A. S., Winearls, James, Mutch, Nicola J., Laffan, Mike A., Curry, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511733/ https://www.ncbi.nlm.nih.gov/pubmed/36163263 http://dx.doi.org/10.1186/s13054-022-04167-x |
Ejemplares similares
-
Fibrinogen Early In Severe Trauma studY (FEISTY): results from an Australian multicentre randomised controlled pilot trial
por: Winearls, James, et al.
Publicado: (2023) -
The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis
por: Whyte, Claire S., et al.
Publicado: (2022) -
Fibrinogen Early In Severe paediatric Trauma studY (FEISTY junior): protocol for a randomised controlled trial
por: George, Shane, et al.
Publicado: (2022) -
Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia
por: Crispin, Philip, et al.
Publicado: (2021) -
Fibrinogen Early In Severe Trauma studY (FEISTY): study protocol for a randomised controlled trial
por: Winearls, James, et al.
Publicado: (2017)